0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Research Letters |

Interstitial Keratitis Following Varicella Vaccination FREE

Agnieszka Nagpal, MD; Robin Vora, MD; Todd P. Margolis, MD, PhD; Nisha R. Acharya, MD, MS
Arch Ophthalmol. 2009;127(2):222-229. doi:10.1001/archophthalmol.2008.569.
Text Size: A A A
Published online

Varicella is a highly transmissible disease caused by the varicella-zoster virus, with the most common manifestations being a maculopapular and/or vesicular rash accompanied by a fever. Current vaccination recommendations by the Advisory Committee on Immunization Practices include the administration of a vaccine for the prevention of varicella in children.1 Rare cases of ocular disease (sclerokeratouveitis and anterior uveitis) following varicella vaccination have been reported in the literature, associated with both the live attenuated Oka strain used in the vaccine and the wild-type virus.2,3 We report a case of avascular interstitial keratitis following the administration of the varicella vaccine. To our knowledge, this complication of the Oka strain vaccine has not been previously reported.

An 11-year-old girl was referred for new-onset blurry vision in the right eye 2 weeks after being vaccinated with the Oka strain of the varicella-zoster virus (Varivax; Merck and Co, Inc, Whitehouse Station, New Jersey). A standard dose of 0.5 mL was injected into the left deltoid without any resulting skin reaction. Her medical history was significant for mild eczema and a seizure disorder treated with daily oral levetiracetam, and results of an ocular examination 1 year prior were normal. One week following the administration of the vaccine, she developed rhinitis and a mild fever that lasted 2 days. Two weeks following the vaccination, she noted blurry vision and photophobia in the right eye and her mother noted 3 white spots on the cornea. On examination, visual acuity measured 20/30 OD and 20/20 OS. Corneal sensation was normal in both eyes. Intraocular pressure measured 14 mm Hg OD and 18 mm Hg OS. There was no conjunctival injection or anterior chamber inflammation. In the right cornea, there were several well-circumscribed avascular opacities that appeared to be white blood cells at varying stromal depths (Figure 1). The left eye was unaffected. The posterior segment examination results were normal in both eyes. Epstein-Barr virus DNA was not detected by polymerase chain reaction. The patient was treated with a 1-month course of prednisolone acetate, 1%, starting at 4 times per day, with resolution of the interstitial keratitis at 2 weeks and return of visual acuity to 20/20 OD (Figure 2). At the 6-month follow-up visit, there was no sign of recurrence.

Place holder to copy figure label and caption
Figure 1.

Interstitial keratitis before treatment with well-circumscribed avascular opacities at varying stromal depths (A), and a slitbeam showing stromal opacity (B).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Improved interstitial keratitis following corticosteroid treatment.

Graphic Jump Location

Complications of the Varivax vaccine have included disease caused by both wild-type and Oka strain varicella-zoster virus. There are few reports of ocular manifestations after varicella vaccination in the literature, and we found no previous reports describing avascular interstitial keratitis. In the case that we have reported, the close temporal association of the vaccination and the development of a corticosteroid-responsive keratitis lead us to suggest that this complication represented an immune-mediated response to the vaccine strain. One possible explanation for the unilaterality is that she rubbed 1 eye with a hand that had previously touched her site of inoculation, leading to unilateral antigen presentation to the cornea and unilateral disease. Unilateral disease has frequently been described following smallpox vaccination, presumably from this type of touch.4 In addition, systemic diseases may also manifest unilaterally. Immune-mediated interstitial keratitis should be recognized as a possible adverse effect of the varicella vaccine.

Correspondence: Dr Acharya, Francis I. Proctor Foundation for Research in Ophthalmology, University of California, San Francisco, 95 Kirkham St, San Francisco, CA 94143-0944 (nisha.acharya@ucsf.edu).

Author Contributions: Dr Acharya had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Financial Disclosure: None reported.

Funding/Support: This work was supported by grant EY06190 from the National Eye Institute and an unrestricted grant from Research to Prevent Blindness. Dr Acharya is supported by grant K23EY017897 from the National Eye Institute and a Research to Prevent Blindness Career Development Award.

Role of the Sponsors: The sponsors had no role in the design or conduct of the study, data analysis, or manuscript preparation.

Centers for Disease Control and Prevention, Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996;45 ((RR-11)) 1- 36
PubMed
Esmaeli-Gutstein  BWinkelman  JZ Uveitis associated with varicella virus vaccine. Am J Ophthalmol 1999;127 (6) 733- 734
PubMed Link to Article
Naseri  AGood  WVCunningham  ET  Jr Herpes zoster virus sclerokeratitis and anterior uveitis in a child following varicella vaccination. Am J Ophthalmol 2003;135 (3) 415- 417
PubMed Link to Article
Pepose  JSMargolis  TPLaRussa  PPavan-Langston  D Ocular complications of smallpox vaccination. Am J Ophthalmol 2003;136 (2) 343- 352
PubMed Link to Article

Figures

Place holder to copy figure label and caption
Figure 1.

Interstitial keratitis before treatment with well-circumscribed avascular opacities at varying stromal depths (A), and a slitbeam showing stromal opacity (B).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Improved interstitial keratitis following corticosteroid treatment.

Graphic Jump Location

Tables

References

Centers for Disease Control and Prevention, Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996;45 ((RR-11)) 1- 36
PubMed
Esmaeli-Gutstein  BWinkelman  JZ Uveitis associated with varicella virus vaccine. Am J Ophthalmol 1999;127 (6) 733- 734
PubMed Link to Article
Naseri  AGood  WVCunningham  ET  Jr Herpes zoster virus sclerokeratitis and anterior uveitis in a child following varicella vaccination. Am J Ophthalmol 2003;135 (3) 415- 417
PubMed Link to Article
Pepose  JSMargolis  TPLaRussa  PPavan-Langston  D Ocular complications of smallpox vaccination. Am J Ophthalmol 2003;136 (2) 343- 352
PubMed Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

698 Views
6 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
Jobs